CKD-375

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Type 2 Diabetes MellitusType2 Diabetes Mellitus

Phase 1

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375

Chong Kun Dang PharmaceuticalType 2 Diabetes Mellitus

Start: 2019-04-14End: 2019-05-01Target: 28Updated: 2019-03-06

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

Chong Kun Dang PharmaceuticalType2 Diabetes Mellitus

Start: 2020-01-29End: 2020-06-08Target: 26Updated: 2020-01-09